My Account
Virbac USA veterinary site

Antibiotic

Protect Your Investment

Download Prescribing Information

Also offering

Available for use in cattle and swine.

Download Prescribing Information Learn More

You’ve trusted your herd with tulathromycin.

Now you need Tulissin® 25 injectable solution

  • Provides up to 9 days of lung activity to treat and control SRD 1

  • Can be added to judicious antibiotic use protocols

  • Formulated for weaned pigs to allow for accurate dosing

  • Highest quality standard

    (produced in an FDA/EMA Approved manufacturing facility)

  • One dose means you only have to handle them once

  • Goes to work in minutes2

    Concentrates in the lungs1,3

Treat and control

Indicated for the treatment of Swine Respiratory Disease (SRD)

Treat

Tulissin 25® injectable solution is indicated for the treatment of swine respiratory disease (SRD) associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Bordetella bronchiseptica, Haemophilus parasuis, and Mycoplasma hyopneumoniae.  Do not inject more than 4 mL per injection site. Swine intended for human consumption must not be slaughtered within 5 days from the last treatment.

Control

Tulissin 25® injectable solution is indicated for the the control of SRD associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, and Mycoplasma hyopneumoniae in groups of pigs where SRD has been diagnosed.  Not for use in animals previously found to be hypersensitive to the drug.

Two concentrations for added flexibility based on weight

Swine-Brochure_pigs_sm.jpg

  • Tulissin® 25 injectable solution is formulated for weaned pigs for increased precision
  • Tulissin 25 mg/mL For swine: 1 mL/22 lb. BW

 

Swine-Brochure_pigs_lg.jpg

  • Tulissin® 100 (tulathromycin injection) is available for use in larger pigs. Note effects on swine reproduction and lactation have not been determined.
Our Companion in the Swine Business

Marketed By:

Pharmgate-AnimalHealth_Logo_RGB-Medium-NoBackground (2).png

Important Swine Safety Information

Tulissin 25® injectable solution

Logo-Tulissin-25.svg

  • Do not inject more than 4 mL per injection site
  • Pre-slaughter withdrawal 5 days
  • Effects on reproduction have not been determined
  • There may be trim loss at the injection site at slaughter
  • Do not use in animals known to be hypersensitive to the product
  • Not for use in use in humans, chickens or turkeys

Prescribing-Information_button.jpg

Tulissin 100® injectable solution

Logo-Tulissin-100.svg

  • Do not inject more than 2.5 mL per injection site
  • Pre-slaughter withdrawal 5 days
  • Effects on reproduction have not been determined
  • There may be trim loss at the injection site at slaughter
  • Do not use in animals known to be hypersensitive to the product
  • Not for use in use in humans, chickens or turkeys

Prescribing-Information_button.jpg

Need more information?

Contact form

References

  1. Waag TA, Bradford JR, Lucas MJ, et al. Duration of effectiveness of tulathromycin injectable solution in an Actinobacillus pleuropneumoniae respiratory-disease challenge model in swine. J Swine Health Prod. 2008;16(3):126–130.

  2. Villarino N, Brown SA, Martín-Jiménez T. Understanding the pharmacokinetics of tulathromycin: a pulmonary perspective. J. Vet Pharmacol. Therap. 37, 211- 221.

  3. Benchaoui HA, Nowakowski M, Sherington J, Rowan TG, Sunderland SJ. Pharmacokinetics and lung tissue concentrations of tulathromycin in swine. J. Vet Pharmacolo. Therap. 2004;27(4):203-210.)